Scenic Biotech’s Post

Building a competitive landscape and create a booming biopharma ecosystem requires support across borders. Global leaders in life sciences will share their experience with business, investment, and regulations while working in Asia, and how they have been able to meet or surpass expectations. ATLATL is sharing its insights at the Asia Bio Partnering Forum, focusing on international collaboration to foster growth in biopharma ecosystems. #AsiaBio 2024

Today is your last chance to save with Advanced Registration rates for the 24th Bio€quity Europe. Join BioCentury Inc. and EBD Group in San Sebastián, Spain, Basque Country, for this destination event designed for biopharma decision-makers and investors. ➤ Debate how to 'rise above the noise' and reach the discussion stage with investors and pharma. ➤ Network and partner with VCs, CEOs, and BD&L leaders. ➤ Discover 100+ emerging biotechs selected for the Presenting, Next Wave, and Pre-Seed Company Tracks. ➤ Dive into European biotech trends with an exclusive conference report from Insights Partner McKinsey & Company. Register by midnight PST to save with Advanced Registration: https://ow.ly/aSB850R6KU3 Download the conference brochure to learn who you will meet and the agenda: https://ow.ly/1KEi50R6KU2 Special thanks to our Regional Host Committee Diputación Foral de Guipuzcoa and Ysios Capital, and to our Founding Sponsor Sofinnova Partners. #bioequityeurope #biopharma #biotech #lifesciences #bioeurope #bioeuropespring #VCs

Calluna Pharma is attending Bio€quity Europe conference, taking place 12-14 May, organized by BioCentury Inc. and EBD Group. Our CEO John Montana is going to be in San Sebastian next week for one of Europe’s top experiences for CEOS and investors to network, partner and discuss key issues facing the biotech industry. This is an opportunity to learn more about how to reach discussion stage with investors, discover 100+ emerging biotechs, and dive into European biotech trends. Find out more, and join us here: https://lnkd.in/dzunkQc #Biotech #Pharma #VentureCapital #BioEquityEurope #BioEquity

🔊 (sound on) Yesterday in Montreal, BIOTECanada brought together its members in Quebec, invited guests, and key stakeholders to Espace CDPQ for a lively panel discussion on enhancing Canada’s regulatory competitiveness and the attraction of investment into the biotechnology sector in Canada. Highlights included: * The pivotal role and intrinsic value of anchor companies within the expansive biotech ecosystem * Strategies for Canada to secure and retain biotech companies * Insights into the venture capital landscape and the broader investment climate * How organizations such as the Fonds de solidarité FTQ, as institutional investors, navigate the biotech innovation space, focusing on capital availability, investment opportunities, returns and the mandate on behalf of Quebecers * The crucial role of leveraging talent and mentorship opportunities to drive significant economic impact. A heartfelt thank you to our esteemed panelists: Mounia Azzi, PhD, Geneviève Guertin, Michael Mee, our host, Amplitude Ventures and to everyone who attended the event, your engagement fuels our collective path toward continued success in the biotech ecosystem. What was your most notable take-away from the event? If you missed the event, stay tuned for more opportunities to connect with us! Let’s keep the momentum going! #biotech #Canada #investment #innovation #policy #ecosystem #lifesciences #quebec adMare BioInnovations, J.P. Morgan, Ventus Therapeutics, Centre de production de produits biologiques (CPPB) inc. / Biologics Manufacturing Centre (BMC) Inc., Canadian Advanced Therapies Training Institute, KreaMedica Inc., Mintz, Epitopea, BIOQuebec, Domain Therapeutics, EVAH - Evolution for Animal Health, Health Innovation Capital, Molecular Forecaster, Merck, Thérapeutiques Thryv

Excited to announce that I will be attending Bioeurope Spring, one of the most prominent biotech partnering conferences! Looking forward to connecting with industry leaders, exploring innovative collaborations, and staying up-to-date with the latest trends in the life sciences sector. If you'll be there too, I would love to meet up and discuss potential opportunities. See you at #BioEuropeSpring! #MilliporeCTDMO #Drugconjugate #smallmolecule #HPAPI #linkerpayload"

Seminer Alert! The Future of Biotech: The Role of Legislation on Investment for Innovation The intersecting issues of biotechnology legal regulations and innovation investment processes will be discussed in an online seminar on September 24, 2024. The meeting will be hosted by the European Association for Bioindustries (EuropaBio), a member of the Innovative Health Initiative (IHI). Learn and register: https://lnkd.in/dwk-B9FH #innovation #biotech #europabio #Bioindustries #IHI

Should biotech companies consider pricing implications for Early Access Programs? In this snippet from our recent webinar with Fierce Biotech, Andrew Cummins (VP of Business Development) gives his expert thoughts and advice. Download valuable insights from our latest webinar! Visit: https://lnkd.in/eP4C3bFU #ExpandedAccessPrograms #RareDiseases #OrphanDrugs #RealWorldEvidence #MarketAccess #biotechs Mathieu Loiseau Sara Radenovic

Are you wondering how to establish an EAP in Europe without a local presence? Navigating the complexities of setting up and managing an Expanded Access Program (EAP) across 27 diverse European markets can be challenging. If you’re unsure where to start, don’t miss this snippet from our recent webinar with Fierce Biotech. Andrew Cummins, VP of Business Development, shares his expert strategies to successfully launch an EAP in Europe. Download valuable insights from our latest webinar! Visit: https://lnkd.in/eP4C3bFU #ExpandedAccessPrograms #RareDiseases #OrphanDrugs #RealWorldEvidence #MarketAccess #biotechs #Webinarrecap

Don’t miss out on our dedicated track for Strategy and Dealmaking at the Fierce Biotech Summit on Sept 30th – Oct 1st. ➡️Click here to learn more https://ow.ly/BWJR50SzHck Explore the dynamics of partnerships, collaborations, and investments in biotech. Examine the changing landscape of deal structures, innovative licensing models, and successful case studies of strategic alliances. Stay updated on all our events by following Fierce Life Sciences Events #FierceBiotechSummit #WeAreFierce #FierceBiotech #FiercePharma #BiotechPR #BiotechEvents

I’m thrilled to announce that 𝗜’𝗹𝗹 𝗯𝗲 𝗿𝗲𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗶𝗻𝗴 Succelerate AG 𝗮𝘁 𝘁𝗵𝗲 𝘂𝗽𝗰𝗼𝗺𝗶𝗻𝗴 𝗦𝘄𝗶𝘀𝘀 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗗𝗮𝘆, 𝘁𝗮𝗸𝗶𝗻𝗴 𝗽𝗹𝗮𝗰𝗲 𝗼𝗻 𝗔𝗽𝗿𝗶𝗹 𝟮𝟮-𝟮𝟯, 𝟮𝟬𝟮𝟰, 𝗮𝘁 𝘁𝗵𝗲 Messe and Congress Center Basel. As a premier biotechnology conference in Europe, this year's edition seeks to bring together over 2000 participants from the global life sciences community, making it an ideal platform for networking, knowledge exchange, and exploring cutting-edge advancements. 𝗔𝗿𝗲 𝘆𝗼𝘂 𝗽𝗹𝗮𝗻𝗻𝗶𝗻𝗴 𝘁𝗼 𝗮𝘁𝘁𝗲𝗻𝗱 𝗮𝗻𝗱 𝗶𝗻 𝘀𝗲𝗮𝗿𝗰𝗵 𝗼𝗳 𝗰𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝗻𝗰𝘆 𝘀𝗲𝗿𝘃𝗶𝗰𝗲𝘀 𝘁𝗼 𝗲𝗻𝗵𝗮𝗻𝗰𝗲 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝘁𝗵𝗶𝗻𝗸𝗶𝗻𝗴 𝘁𝗵𝗿𝗼𝘂𝗴𝗵𝗼𝘂𝘁 𝘆𝗼𝘂𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗹𝗶𝗳𝗲𝗰𝘆𝗰𝗹𝗲? If so, let's connect! Whether you're 𝗳𝗮𝗰𝗶𝗻𝗴 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 𝗶𝗻 𝗻𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗻𝗴 𝗽𝗼𝗹𝗶𝗰𝘆 𝗹𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲𝘀, 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝗺𝗲𝗻𝘁𝘀, 𝗽𝗮𝘆𝗲𝗿 𝗰𝗼𝗻𝘀𝗶𝗱𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀, 𝗛𝗧𝗔 𝗲𝘃𝗮𝗹𝘂𝗮𝘁𝗶𝗼𝗻𝘀, 𝗼𝗿 𝗺𝗮𝗿𝗸𝗲𝘁 𝗮𝗰𝗰𝗲𝘀𝘀 𝗹𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲𝘀, 𝗼𝗿 𝗶𝗳 𝘆𝗼𝘂'𝗿𝗲 𝘀𝗲𝗲𝗸𝗶𝗻𝗴 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝘁𝗼 𝗼𝗽𝘁𝗶𝗺𝗶𝘇𝗲 𝘆𝗼𝘂𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀, rest assured, we've got you covered. I'd be delighted to discuss how Succelerate can contribute to the success of your endeavors. Swiss Biotech Association #swissbiotechday #BiotechInnovation #Accelerateyoursucces